Success Metrics

Active Trials
0(0%)

Phase Distribution

Ph not_applicable
3
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

0.0%

0 of 3 finished

Non-Completion Rate

100.0%

3 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Terminated(3)

Detailed Status

Withdrawn3

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
N/A
Most Advanced
N/A

Trials by Phase

N/A3 (100.0%)

Trials by Status

withdrawn3100%

Recent Activity

0 active trials
Showing 3 of 3
withdrawnnot_applicable

Use of the Insulin Pump in Cystic Fibrosis Patients With Impaired Glucose Tolerance or CFRD and in Type 1 Diabetes Patients.

NCT00287456
withdrawnnot_applicable

Metabolic Abnormalities in Hispanic Children With Cystic Fibrosis

NCT00287443
withdrawnnot_applicable

Effects of Growth Hormone in Chronically Ill Children

NCT00286689

Clinical Trials (3)

Showing 3 of 3 trials
NCT00287456Not Applicable

Use of the Insulin Pump in Cystic Fibrosis Patients With Impaired Glucose Tolerance or CFRD and in Type 1 Diabetes Patients.

Withdrawn
NCT00287443Not Applicable

Metabolic Abnormalities in Hispanic Children With Cystic Fibrosis

Withdrawn
NCT00286689Not Applicable

Effects of Growth Hormone in Chronically Ill Children

Withdrawn

All 3 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
3